Mayo Clinic

Portfolio Co Investors 2026 for Mayo Clinic: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Mayo Clinic accounts for 24 tracked companies with verified cap-table data, 24 of which disclose round sizes totalling $3.3B. The median disclosed raise is $100M, and the largest is OpenEvidence at $700M, ahead of WHOOP ($575M) and Senda Biosciences ($226M).

The names that recur most often on these co-invested cap tables are Mayo Clinic (24 companies), Sequoia Capital (3 companies), Alexandria Venture Investments (3 companies), Khosla Ventures (3 companies), Matrix Capital Management (2 companies), NTTVC (2 companies). By latest disclosed round, the market skews Series C (8), Series B (8), Series A (4), Series D (1).

Best funded Mayo Clinic companies

  1. OpenEvidence — $700M (latest: Series D)
  2. WHOOP — $575M (latest: Series G)
  3. Senda Biosciences — $226M (latest: Series C)
  4. Glooko — $171M (latest: Series F)
  5. nference — $150M (latest: Series C)
  6. Collaborative Robotics — $140M (latest: Series B)
  7. Endogenex — $138M (latest: Series C)
  8. Medically Home — $112M (latest: Series C)
  9. Pendulum Therapeutics — $111M (latest: Series C)
  10. Vitestro — $102M (latest: Series B)
  11. Inbrain Neuroelectronics — $100M (latest: Series B)
  12. Diagnostic Robotics — $100M (latest: Series B)
  13. Ordr — $90M (latest: Series C)
  14. Anumana — $86M (latest: Series C)
  15. Clarapath — $75M (latest: Series B)

Mayo Clinic Platform — related firms and companies (56)

Mayo Clinic Platform profile · All research reports